Israeli microbiome co BiomX teams with Johnson & Johnson
13 December 2018

Israeli microbiome co BiomX teams with Johnson & Johnson

Israeli microbiome company BiomX, which is developing customized phage therapies, has announced that it has entered into a collaboration with Janssen the therapy R&D arm of...

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse